FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms.

Saved in:
Bibliographic Details
Title: FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms.
Authors: Uittenbogaard P; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands., Netea SA; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, UvA, Amsterdam, Netherlands., Tanck MWT; Department of Epidemiology and Data Science, Amsterdam UMC, Location UvA, Amsterdam, Netherlands., Geissler J; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands., Buda P; Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, Poland., Kowalczyk-Domagała M; Department of Pediatric Cardiology, The Children's Memorial Health Institute, Warsaw, Poland., Okarska-Napierała M; Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland., van Stijn D; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands., Tacke CE; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands., Burgner DP; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia.; Department of Pediatrics, University of Melbourne, Melbourne, VIC, Australia., Shimizu C; Department of Pediatrics, University of California, San Diego, La Jolla, CA, United States., Burns JC; Department of Pediatrics, University of California, San Diego, La Jolla, CA, United States., Kuipers IM; Department of Pediatric Cardiology, Amsterdam UMC, UvA, Amsterdam, Netherlands., Kuijpers TW; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands.; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands., Nagelkerke SQ; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam (UvA), Amsterdam, Netherlands.; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (Amsterdam UMC), UvA, Amsterdam, Netherlands.
Corporate Authors: US Kawasaki Disease Genetics Consortium
Source: Frontiers in immunology [Front Immunol] 2024 Sep 18; Vol. 15, pp. 1323171. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1323171